| Utestående aktier | 88,223,883 shares |
| Insideraktier | 17 825 107 shares |
| Insynsägande | 20,20 % |
| Totalt antal insynspersoner | 16 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
2083 out of 11219Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Cognition Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
BIOS Fund III NT, LP
10% Owner -
|
1 424 014 | 6 048 500 | |
|
BIOS Memory SPV I, LP
10% Owner -
|
1 424 014 | 6 048 500 | |
|
Bios Clinical Opportunity Fund, LP
Director, 10% Owner -
[D]
|
1 000 190 | 1 000 190 | |
| Breedlove Mark H. Director - [D] | 404 439 | 404 439 | |
| Anthony Caggiano Chief Medical Officer - [O] | 463 273 | 463 273 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| John Brendan Doyle Chief Financial Officer - [O] | 425 350 | 425 350 | |
|
Fletcher Aaron G.L.
Director, 10% Owner -
[D]
|
6 048 500 | 6 048 500 | |
|
Golden Seeds Cognition Therapeutics LLC
10% Owner -
|
0 | 0 | |
| Khattar Jack A. Director - [D] | 48 500 | 48 500 | |
|
Kreis Leslie W.
10% Owner -
|
6 048 500 | 6 048 500 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Brett P Monia Director - [D] | 48 500 | 48 500 | |
| James Michael O'Brien Chief Financial Officer - [O] | 5 000 | 5 000 | |
|
Ogden CAP Associates, LLC
10% Owner -
|
2 210 377 | 2 210 377 | |
| Ellen B Richstone Director - [D] | 58 500 | 58 500 | |
| Lisa Ricciardi CEO & President, Director - [D] [O] | 977 517 | 977 517 | |
| Peggy Wallace Director - [D] | 86 461 | 86 461 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CGTX / Cognition Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CGTX / Cognition Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | 2025-07-29 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 0,6702 | −9 360 | −6 | 425 350 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 30 000 | 434 710 | ||||||
| 2025-07-31 | 2025-07-29 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 0,6702 | −20 281 | −14 | 463 273 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 65 000 | 483 554 | ||||||
| 2025-07-31 | 2025-07-29 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 0,6702 | −23 400 | −16 | 938 666 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 75 000 | 962 066 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | Khattar Jack A. | CGTX | Common Stock | D | 34 000 | 48 500 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | Monia Brett P | CGTX | Common Stock | D | 34 000 | 48 500 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 34 000 | 58 500 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | Wallace Peggy | CGTX | Common Stock | D | 34 000 | 86 461 | ||||||
| 2025-06-20 | 2025-06-18 | 4 | Kreis Leslie W. | CGTX | Common Stock | I | 34 000 | 48 500 | ||||||
| 2025-06-20 | 2025-06-18 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 34 000 | 48 500 | ||||||
| 2025-05-02 | 2025-05-01 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 0,4472 | −9 692 | −4 | 404 710 | ||||
| 2025-02-18 | 2025-02-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 0,5901 | −6 619 | −4 | 887 066 | ||||
| 2025-02-18 | 2025-02-15 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 0,5901 | −1 723 | −1 | 414 402 | ||||
| 2025-02-18 | 2025-02-15 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 0,5901 | −5 296 | −3 | 418 554 | ||||
| 2025-02-04 | 2025-02-04 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 295 000 | 416 125 | ||||||
| 2025-02-04 | 2025-02-04 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 295 000 | 423 850 | ||||||
| 2025-02-04 | 2025-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 0,6660 | −12 779 | −9 | 128 850 | ||||
| 2025-02-04 | 2025-02-04 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 631 300 | 893 685 | ||||||
| 2025-02-04 | 2025-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 0,6660 | −28 960 | −19 | 262 385 | ||||
| 2025-02-04 | 2025-01-31 | 4 | Ricciardi Lisa By Spouse | CGTX | Common Stock | I | 0,7722 | 38 851 | 30 | 38 851 | ||||
| 2024-06-11 | 2024-06-07 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 8 500 | 14 500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Kreis Leslie W. | CGTX | Common Stock | I | 8 500 | 14 500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Wallace Peggy | CGTX | Common Stock | D | 8 500 | 52 461 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 8 500 | 24 500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Khattar Jack A. | CGTX | Common Stock | D | 8 500 | 14 500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Monia Brett P | CGTX | Common Stock | D | 8 500 | 14 500 | ||||||
| 2024-05-03 | 2024-05-01 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 1,9500 | −8 699 | −17 | 121 125 | ||||
| 2024-03-14 | 2024-03-14 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,7500 | 5 700 | 10 | 291 345 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 60 000 | 141 629 | ||||||
| 2024-02-20 | 2024-02-15 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 20 000 | 129 824 | ||||||
| 2024-02-20 | 2024-02-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 75 000 | 285 645 | ||||||
| 2024-02-09 | 2024-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 2,2900 | −12 777 | −29 | 81 629 | ||||
| 2024-02-09 | 2024-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 2,2900 | −27 828 | −64 | 210 645 | ||||
| 2023-11-13 | 3 | Bios Clinical Opportunity Fund, LP | CGTX | Common Stock | D | 500 095 | ||||||||
| 2023-11-13 | 2023-11-08 | 4 | Fletcher Aaron G.L. By Bios Clinical Opportunity Fund, LP | CGTX | Common Stock | I | 1,0500 | 500 095 | 525 | 500 095 | ||||
| 2023-11-13 | 2023-11-08 | 4 | Kreis Leslie W. By Bios Clinical Opportunity Fund, LP | CGTX | Common Stock | I | 1,0500 | 500 095 | 525 | 500 095 | ||||
| 2023-06-13 | 2023-06-09 | 4 | Kreis Leslie W. | CGTX | Common Stock | I | 6 000 | 6 000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 6 000 | 6 000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Wallace Peggy | CGTX | Common Stock | D | 6 000 | 43 961 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Monia Brett P | CGTX | Common Stock | D | 6 000 | 6 000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Khattar Jack A. | CGTX | Common Stock | D | 6 000 | 6 000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 6 000 | 16 000 | ||||||
| 2023-05-03 | 2023-05-01 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 109 824 | 109 824 | ||||||
| 2023-02-07 | 2023-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 213 973 | 238 473 | ||||||
| 2023-02-07 | 2023-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 94 406 | 94 406 | ||||||
| 2022-11-29 | 2022-11-29 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 2,6550 | 10 000 | 27 | 10 000 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP | CGTX | Common Stock | I | 2,6497 | 1 871 | 5 | 309 748 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Fletcher Aaron G.L. By Bios Fund III QP, LP | CGTX | Common Stock | I | 2,6497 | 12 220 | 32 | 2 021 906 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Fletcher Aaron G.L. By Bios Fund III NT, LP | CGTX | Common Stock | I | 2,6497 | 1 973 | 5 | 326 733 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Kreis Leslie W. By Bios Fund III, LP | CGTX | Common Stock | I | 2,6497 | 1 871 | 5 | 309 748 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Kreis Leslie W. By Bios Fund III QP, LP | CGTX | Common Stock | I | 2,6497 | 12 220 | 32 | 2 021 906 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Kreis Leslie W. By Bios Fund III NT, LP | CGTX | Common Stock | I | 2,6497 | 1 973 | 5 | 326 733 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Fletcher Aaron G.L. Bios Fund III, LP | CGTX | Common Stock | I | 1,4000 | 8 269 | 12 | 307 877 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Fletcher Aaron G.L. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,4000 | 54 009 | 76 | 2 009 686 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Fletcher Aaron G.L. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,4000 | 8 722 | 12 | 324 760 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Kreis Leslie W. Bios Fund III, LP | CGTX | Common Stock | I | 1,4000 | 8 269 | 12 | 307 877 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Kreis Leslie W. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,4000 | 54 009 | 76 | 2 009 686 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Kreis Leslie W. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,4000 | 8 722 | 12 | 324 760 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Wallace Peggy | CGTX | Common Stock | D | 1,2000 | 12 500 | 15 | 37 961 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,3000 | 12 000 | 16 | 24 500 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Fletcher Aaron G.L. Bios Fund III, LP | CGTX | Common Stock | I | 1,2000 | 174 700 | 210 | 299 608 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Fletcher Aaron G.L. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,2000 | 1 141 030 | 1 369 | 1 955 677 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Fletcher Aaron G.L. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,2000 | 184 270 | 221 | 316 038 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Kreis Leslie W. Bios Fund III, LP | CGTX | Common Stock | I | 1,2000 | 174 700 | 210 | 299 608 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Kreis Leslie W. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,2000 | 1 141 030 | 1 369 | 1 955 677 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Kreis Leslie W. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,2000 | 184 270 | 221 | 316 038 | ||||
| 2022-09-29 | 2022-09-27 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | −2 489 682 | 0 | ||||||
| 2022-09-29 | 2022-09-27 | 4 | Wallace Peggy | CGTX | Common Stock | D | 22 461 | 25 461 | ||||||
| 2022-03-25 | 2022-03-23 | 4 | O'Brien James Michael | CGTX | Stock Option (right to buy) | D | 3,05 | 50 000 | 50 000 | |||||
| 2022-03-25 | 2022-03-23 | 4 | Caggiano Anthony | CGTX | Stock Option (right to buy) | D | 3,05 | 25 000 | 25 000 | |||||
| 2022-02-01 | 2022-01-31 | 4 | Fletcher Aaron G.L. By BP Directors, LP | CGTX | Stock Option (right to buy) | I | 1,75 | 1 145 | 1 145 | |||||
| 2022-02-01 | 2022-01-31 | 4 | Fletcher Aaron G.L. | CGTX | Stock Option (right to buy) | D | 1,75 | −1 145 | 2 719 | |||||
| 2022-02-01 | 2021-10-13 | 4/A | BIOS Memory SPV I, LP | CGTX | Common Stock | D | 1 424 014 | 1 424 014 | ||||||
| 2022-02-01 | 2021-10-13 | 4/A | Fletcher Aaron G.L. By Bios Memory SPV I, LP | CGTX | Common Stock | I | 1 424 014 | 1 424 014 | ||||||
| 2021-11-10 | 2021-11-01 | 4 | Caggiano Anthony | CGTX | Stock Option (right to buy) | D | 12,10 | 161 676 | 161 676 | |||||
| 2021-11-03 | 2021-11-01 | 4 | RICHSTONE ELLEN B | CGTX | Stock Option (right to buy) | D | 12,10 | 16 670 | 16 670 | |||||
| 2021-10-25 | 2021-10-13 | 4 | Wallace Peggy | CGTX | Common Stock | D | 12,0000 | 3 000 | 36 | 3 000 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Simple Agreement for Future Equity | I | −25 593 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Simple Agreement for Future Equity | I | −158 476 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Simple Agreement for Future Equity | I | −24 263 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Warrant (right to buy) | I | 0,03 | −33 495 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −111 504 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −1 930 673 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −134 626 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −110 744 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −1 138 040 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −827 275 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −253 256 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, QP, LP. | CGTX | Series B Convertible Preferred Stock | I | −792 547 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, LP. | CGTX | Series B Convertible Preferred Stock | I | −1 355 017 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP | CGTX | Series B Convertible Preferred Stock | D | −4 605 985 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 25 593 | 60 065 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 34 472 | 34 472 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 12,0000 | 144 530 | 1 734 | 899 905 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 158 476 | 755 375 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 596 899 | 596 899 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Common Stock | I | 12,0000 | 22 129 | 266 | 88 012 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Common Stock | I | 24 263 | 65 883 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Common Stock | I | 41 620 | 41 620 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 12,0000 | −90 | −1 | 385 248 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 0,0320 | 33 495 | 1 | 385 339 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 351 844 | 351 844 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 12,0000 | 23 341 | 280 | 57 579 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 34 238 | 34 238 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, QP, LP. | CGTX | Common Stock | I | 255 765 | 255 765 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, LP. | CGTX | Common Stock | I | 78 298 | 78 298 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, QP, LP. | CGTX | Common Stock | I | 245 029 | 245 029 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, LP. | CGTX | Common Stock | I | 418 926 | 418 926 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP | CGTX | Common Stock | D | 1 424 014 | 1 424 014 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Warrant (right to buy) | D | 0,03 | −27 471 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series B-1 Convertible Preferred Stock | D | −438 854 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series B Convertible Preferred Stock | D | −4 087 046 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series A-2 Convertible Preferred Stock | D | −882 233 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series A-1 Convertible Preferred Stock | D | −333 333 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series A Convertible Preferred Stock | D | −1 319 408 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 12,0000 | −74 | −1 | 2 210 377 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 0,0320 | 27 471 | 1 | 2 210 452 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 135 679 | 2 182 981 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 1 263 575 | 2 047 302 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 272 756 | 783 727 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 103 055 | 510 971 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 407 916 | 407 916 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series A-1 Convertible Preferred Stock | D | −884 058 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Simple Agreement for Future Equity | D | 0 | |||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Warrant (right to buy) | D | 0,03 | −12 276 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series B-1 Convertible Preferred Stock | D | −1 574 370 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series B Convertible Preferred Stock | D | −4 004 181 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series A-2 Convertible Preferred Stock | D | −542 496 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 311 706 | 2 489 691 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 12,0000 | −33 | −0 | 2 177 985 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 0,0320 | 12 276 | 0 | 2 178 019 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 486 742 | 2 165 743 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 1 237 959 | 1 679 001 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 167 721 | 441 042 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 273 321 | 273 321 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Simple Agreement for Future Equity | I | −25 593 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Simple Agreement for Future Equity | I | −158 476 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Simple Agreement for Future Equity | I | −24 263 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Warrant (right to buy) | I | 0,03 | −33 495 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −111 504 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −1 930 673 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −134 626 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −110 744 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −1 138 040 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −827 275 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | −253 256 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, QP, LP. | CGTX | Series B Convertible Preferred Stock | I | −792 547 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP. | CGTX | Series B Convertible Preferred Stock | I | −1 355 017 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. | CGTX | Series B Convertible Preferred Stock | D | −4 605 985 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 25 593 | 60 065 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 34 472 | 34 472 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 12,0000 | 144 530 | 1 734 | 899 905 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 158 476 | 755 375 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 596 899 | 596 899 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Common Stock | I | 12,0000 | 22 129 | 266 | 88 012 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Common Stock | I | 24 263 | 65 883 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Common Stock | I | 41 620 | 41 620 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 12,0000 | −90 | −1 | 385 248 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 0,0320 | 33 495 | 1 | 385 339 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 351 844 | 351 844 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 12,0000 | 23 341 | 280 | 57 579 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 34 238 | 34 238 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, QP, LP. | CGTX | Common Stock | I | 255 765 | 255 765 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP. | CGTX | Common Stock | I | 78 298 | 78 298 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, QP, LP. | CGTX | Common Stock | I | 245 029 | 245 029 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP. | CGTX | Common Stock | I | 418 926 | 418 926 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV I, LP. | CGTX | Common Stock | I | 1 424 014 | 1 424 014 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Warrant (Right to Buy) | I | 0,03 | −4 354 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series B-1 Convertible Preferred Stock | I | −301 978 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series B Convertible Preferred Stock | I | −826 278 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series A-2 Convertible Preferred Stock | I | −118 835 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series A-1 Convertible Preferred Stock | I | −144 928 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 12,0000 | −12 | −0 | 404 439 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 0,0320 | 4 354 | 0 | 404 451 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 93 296 | 400 097 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 225 281 | 306 801 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 36 714 | 81 520 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 44 806 | 44 806 | ||||||
| 2021-10-14 | 2021-10-13 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 12,0000 | 12 500 | 150 | 12 500 | ||||
| 2021-10-14 | 2021-10-13 | 4 | O'Brien James Michael | CGTX | Common Stock | D | 12,0000 | 5 000 | 60 | 5 000 | ||||
| 2021-10-12 | 2021-10-07 | 4 | Ricciardi Lisa | CGTX | Stock Option (right to buy) | D | 12,00 | 290 509 | 290 509 | |||||
| 2021-10-12 | 2021-10-07 | 4 | Ricciardi Lisa | CGTX | Stock Option (right to buy) | D | 12,00 | 290 509 | 290 509 | |||||
| 2021-10-12 | 2021-10-07 | 4 | Ricciardi Lisa | CGTX | Stock Option (right to buy) | D | 12,00 | 547 965 | 547 965 | |||||
| 2021-10-12 | 2021-10-07 | 4 | O'Brien James Michael | CGTX | Stock Option (right to buy) | D | 12,00 | 54 457 | 54 457 | |||||
| 2021-10-07 | 3 | Breedlove Mark H. | CGTX | Common Stock | D | 7 611 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
